Abstract
<h3>Introduction</h3> The classification of clinical disorders associated with an abnormal secretion of aldosterone was clearly outlined by Conn.<sup>1</sup>Primary hyperaldosteronism had been previously described by Conn<sup>2</sup>and secondary hyperaldosteronism in patients with nephrosis, congestive heart failure, and cirrhosis by Deming, Luetscher, and Curtis.<sup>3,4</sup>Although the syndrome of primary hypoaldosteronism had not been described, it was anticipated by Conn,<sup>1</sup>and subsequently two patients have been reported as representing examples of this syndrome.<sup>5,6</sup>The exact pathophysiology of primary hypoaldosteronism is still in doubt.<sup>7</sup> Although increased aldosterone secretion is not necessarily the primary cause of sodium and water retention in patients with edema, it is, in general, one constant finding in the chain of events leading to edema formation. Two groups of substances have been used to modify this aspect of edema; inhibitors of adrenal cortical activity<sup>8</sup>and peripheral antagonists of aldosterone.<sup>9</sup>The therapeutic usefulness of the adrenal inhibitor used most extensively,
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
